Lista de obras -

Basic clinical parameters predict gefitinib efficacy in non-small cell lung cancer

artículo científico publicado el 1 de septiembre de 2011

Biomarkers of evasive resistance predict disease progression in cancer patients treated with antiangiogenic therapies

artículo científico publicado en 2016

Clinicopathologic Features and Prognostic Impact of Lymph Node Involvement in Patients With Breast Implant-associated Anaplastic Large Cell Lymphoma

artículo científico publicado en 2017

Cloak and dagger - secondary hemophygocytic lymphohistiocytosis caused by intravenous autoinfection

artículo científico publicado en 2019

Corrigendum: Methylation of ribosomal RNA by NSUN5 is a conserved mechanism modulating organismal lifespan.

artículo científico publicado en 2016

Docetaxel in the treatment of non-small cell lung cancer (NSCLC) -- an observational study focusing on symptom improvement.

artículo científico publicado en 2013

Endothelial Progenitor Cells: Current Issues on Characterization and Challenging Clinical Applications ⬇️

artículo científico publicado el 1 de septiembre de 2012

Hairy Cell Leukemia Patients Have a Normal Life Expectancy—A 35-Year Single-Center Experience and Comparison with the General Population

artículo científico publicado en 2022

High risk of under-grading and -staging in prostate cancer patients eligible for active surveillance

artículo científico publicado en 2015

Latent hypothyreosis as a clinical biomarker for therapy response under abiraterone acetate therapy

Liver cancer: Targeted future options ⬇️

artículo científico publicado el 27 de febrero de 2011

Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registry

artículo científico publicado en 2014

Meta-analysis of clinical metabolic profiling studies in cancer: challenges and opportunities

artículo científico publicado en 2016

Methylation of ribosomal RNA by NSUN5 is a conserved mechanism modulating organismal lifespan.

artículo científico publicado en 2015

Multicenter Phase II Study Evaluating Two Cycles of Docetaxel, Cisplatin and Cetuximab as Induction Regimen Prior to Surgery in Chemotherapy-Naive Patients with NSCLC Stage IB-IIIA (INN06-Study)

artículo científico publicado en 2015

Overcoming immunotherapy resistance in non-small cell lung cancer (NSCLC) - novel approaches and future outlook

scientific article published on 11 September 2020

PD-L1 expression in bladder cancer and metastasis and its influence on oncologic outcome after cystectomy

artículo científico publicado en 2017

Paraneoplastic phenomena and diagnostic challenges in angioimmunoblastic T-cell lymphoma (AITL): report of two cases and review of the literature

artículo científico publicado en 2014

Routine Use of Bendamustine in Patients with Chronic Lymphocytic Leukemia: An Observational Study

artículo científico publicado en 2015

Targeting the insulin-like growth factor network in cancer therapy ⬇️

artículo científico publicado el 15 de abril de 2011

Treg(s) in Cancer: Friends or Foe?

artículo científico publicado en 2015

Tumor vessel disintegration by maximum tolerable PFKFB3 blockade

artículo científico publicado en 2017

Lista de obras de

Basic clinical parameters predict gefitinib efficacy in non-small cell lung cancer

Biomarkers of evasive resistance predict disease progression in cancer patients treated with antiangiogenic therapies

Clinicopathologic Features and Prognostic Impact of Lymph Node Involvement in Patients With Breast Implant-associated Anaplastic Large Cell Lymphoma

Cloak and dagger - secondary hemophygocytic lymphohistiocytosis caused by intravenous autoinfection

Corrigendum: Methylation of ribosomal RNA by NSUN5 is a conserved mechanism modulating organismal lifespan.

Docetaxel in the treatment of non-small cell lung cancer (NSCLC) -- an observational study focusing on symptom improvement.

Endothelial Progenitor Cells: Current Issues on Characterization and Challenging Clinical Applications ⬇️

Hairy Cell Leukemia Patients Have a Normal Life Expectancy—A 35-Year Single-Center Experience and Comparison with the General Population

High risk of under-grading and -staging in prostate cancer patients eligible for active surveillance

Latent hypothyreosis as a clinical biomarker for therapy response under abiraterone acetate therapy

Liver cancer: Targeted future options ⬇️

Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registry

Meta-analysis of clinical metabolic profiling studies in cancer: challenges and opportunities

Methylation of ribosomal RNA by NSUN5 is a conserved mechanism modulating organismal lifespan.

Multicenter Phase II Study Evaluating Two Cycles of Docetaxel, Cisplatin and Cetuximab as Induction Regimen Prior to Surgery in Chemotherapy-Naive Patients with NSCLC Stage IB-IIIA (INN06-Study)

Overcoming immunotherapy resistance in non-small cell lung cancer (NSCLC) - novel approaches and future outlook

PD-L1 expression in bladder cancer and metastasis and its influence on oncologic outcome after cystectomy

Paraneoplastic phenomena and diagnostic challenges in angioimmunoblastic T-cell lymphoma (AITL): report of two cases and review of the literature

Routine Use of Bendamustine in Patients with Chronic Lymphocytic Leukemia: An Observational Study

Targeting the insulin-like growth factor network in cancer therapy ⬇️

Treg(s) in Cancer: Friends or Foe?

Tumor vessel disintegration by maximum tolerable PFKFB3 blockade